BlueRock Therapeutics Wins $1M from NY State for R&D Hub, Launches MSK Neuro Collaboration

Cell-based therapy developer BlueRock Therapeutics said today it will receive $1 million from New York State for establishing a neuroscience R&D hub in New York City—a hub whose activity will include a new research collaboration with Memorial Sloan-Kettering Cancer Center (MSK), from which the company was spun out in 2016.Headquartered in Cambridge, MA, BlueRock is building out a 7800-square-foot space within the Alexandria Center for Life Science, the 728,000-square-foot Manhattan cam